The Defence Analysis and Growth Organisation (DRDO) on Tuesday issued instructions on the utilization of the brand new COVID-19 drug 2-DG.
The DRDO stated that sufferers with uncontrolled diabetes, extreme cardiac drawback, acute respiratory misery syndrome (ARDS), extreme hepatic and renal impairment needs to be cautious earlier than taking this medication. The drug could be given to sufferers beneath the care and prescription of medical doctors, DRDO stated.
The anti-COVID-19 drug shouldn’t be given to pregnant and lactating ladies and sufferers beneath 18 years, it stated.
“Ideally, 2DG needs to be prescribed as early as attainable by medical doctors for reasonable to extreme Covid sufferers for a most period of as much as 10 days,” DRDO stated.
The 2DG medication could be given to Covid-19 sufferers beneath the care and prescription of medical doctors. Instructions for utilization of this drug for Covid-19 sufferers as per DCGI approval are hooked up right here for reference. For all queries concerning #2DG, please write to 2DG@drreddys.com pic.twitter.com/x19ayBoToG
— DRDO (@DRDO_India) June 1, 2021
The Drug Controller of India (DCGI) in early Might authorised the drug ‘2-Deoxy-D-glucose’ to be used in emergency conditions on delicate and extreme sufferers of coronavirus. The primary consignment of this drug was launched on 17 Might by Defence Minister Rajnath Singh and Well being Minister Harsh Vardhan.
The drug is available in powder type and could be taken with water. It may very well be a game-changer within the battle towards the pandemic because it helps in sooner restoration of hospitalised sufferers and reduces oxygen dependence.
Medical trial outcomes have proven that the drug helps in sooner restoration of hospitalised sufferers and reduces supplemental oxygen dependence. Larger proportion of sufferers handled with 2-DG confirmed RT-PCR detrimental conversion in Covid sufferers.